Abstract
The aim of this rapid review was to assess how dental aerosol generating procedures (AGPs) were defined in international dental guidelines, what mitigation processes were advised and whether they were linked to COVID-19 epidemiology. The specific objectives were:
• Assess how aerosol generating procedures (AGPs) are defined and classified in international guidelines
• Identify what AGP mitigation is advised for both COVID and non-COVID patients
• Report recommended time gaps (fallow periods) between treating COVID and non-
COVID patients in the same surgery following provision of AGPs
• Identify any mitigating factors that allow reductions in the length of fallow periods.
• (Assess whether there is a relationship between COVID-19 epidemiology and World Bank income status with PPE provision – to be reported later).
• (Assess the quality of linked evidence to recommendations – currently in progress to be reported later).
• Assess how aerosol generating procedures (AGPs) are defined and classified in international guidelines
• Identify what AGP mitigation is advised for both COVID and non-COVID patients
• Report recommended time gaps (fallow periods) between treating COVID and non-
COVID patients in the same surgery following provision of AGPs
• Identify any mitigating factors that allow reductions in the length of fallow periods.
• (Assess whether there is a relationship between COVID-19 epidemiology and World Bank income status with PPE provision – to be reported later).
• (Assess the quality of linked evidence to recommendations – currently in progress to be reported later).
| Original language | English |
|---|---|
| Publisher | Cochrane Oral Health |
| Number of pages | 69 |
| Publication status | Published - 24 Jul 2020 |
Bibliographical note
The COVID-19 Dental Services Evidence Review Working Group would like to thank and acknowledge the contribution of the following individuals for providing the advice and access to the international guidance documents necessary for this rapid review: Colette Bridgman, Chief Dental Officer, Wales; Alonso Carrasco-Labra, Director, ADA Science & Research Institute; Riana Clarke, National Clinical Director Oral Health, New Zealand; Michael Donaldson, Chief Dental Officer, Northern Ireland; Tom Ferris, Chief Dental Officer, Scotland; Sara Hurley, Chief Dental Officer, England; Paulo Melo, COVID19 Task Team Chair, FDI World Dental Federation; Timothy Ricks, Chief Dental Officer, US Public Health Service; James Taylor, Chief Dental Officer, Canada; Benoit Varenne, Dental Officer, World Health Organization. Thanks also to Tif Qureshi for providing access to some international guidance documents.The COVID-19 Dental Services Evidence Review Working Group are grateful to for the help and support provided by Shona Floate, University of Glasgow; Anne Littlewood, and Laura MacDonald from Cochrane Oral Health; David Felix, Postgraduate Dental Dean, NES and colleagues from NES’s Clinical Effectiveness workstream: Samantha Rutherford; Douglas Stirling; Michele West; Linda Young.